Long-Term Response to Vemurafenib Therapy in Patients with metastatic malignant Melanoma

被引：0
|
作者：
Groffik, A. [1 ]
Mueller-Brenne, T. [1 ]
Rudolph, B. [1 ]
Rietz, S. [1 ]
Grabbe, S. [1 ]
Loquai, C. [1 ]
机构：
[1] Univ Med Mainz, Hautklin, Mainz, Germany
来源：
JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT | 2013年 / 11卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：908 / 908
页数：1
相关论文
共 50 条
  • [21] Long-Term Remissions in Metastatic Malignant Melanoma Following Chemotherapy and Tamoxifen Maintenance
    Metzner, Bernd
    Casper, Jochen
    Hartung, Gernot
    Rosien, Bernd
    Hoelzle, Erhard
    Pelzer, Peter
    Koehne, Claus-Henning
    ONKOLOGIE, 2011, 34 (04): : 208 - 209
  • [22] Very long-term prognosis of patients with malignant uveal melanoma
    Kujala, E
    Mäkitie, T
    Kivelä, T
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2003, 44 (11) : 4651 - 4659
  • [23] Long-term tolerability of the BRAF inhibitor vemurafenib in patients with metastatic melanoma: Current study data and real-life observations
    Balmelli C.
    Mark M.
    Spirig C.
    Spataro V.
    Pederiva S.
    Monnerat C.
    Zippelius A.
    Wicki A.
    memo - Magazine of European Medical Oncology, 2014, 7 (3) : 181 - 186
  • [24] Long-term stabilization of leptomeningeal disease with whole-brain radiation therapy in a patient with metastatic melanoma treated with vemurafenib: a case report
    Lee, Jee Min
    Mehta, Urvi N.
    Dsouza, Ly H.
    Guadagnolo, Beverly Ashleigh
    Sanders, Deborah L.
    Kim, Kevin B.
    MELANOMA RESEARCH, 2013, 23 (02) : 175 - 178
  • [25] Long-term therapy with ustekinumab for psoriasis in a patient with a history of malignant melanoma
    Gkalpakiotis, Spyridon
    Arenberger, Petr
    Fridman, Marketa
    Arenbergerova, Monika
    DERMATOLOGIC THERAPY, 2017, 30 (06)
  • [26] Cutaneous Manifestations of Vemurafenib Therapy for Metastatic Melanoma
    Owen, Joshua L.
    Lopez, Isha E.
    Desai, Seemal R.
    JOURNAL OF DRUGS IN DERMATOLOGY, 2015, 14 (05) : 509 - 510
  • [27] Survivorship experience for patients (pts) with metastatic melanoma (MM) on long-term targeted therapy (TT).
    Khoo, Chloe Chia Hoey
    Lai-Kwon, Julia Elizabeth
    Lo, Serigne
    Milne, Donna
    Mohamed, Mustafa Abdi
    Raleigh, Jeanette
    Smith, Kortnye Maureen
    Jefford, Michael
    Sandhu, Shahneen Kaur
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [28] Long term results following radiation therapy of locally recurrent and metastatic malignant melanoma
    Seegenschmiedt, MH
    Keilholz, L
    Altendorf-Hofmann, A
    Pieritz, A
    Urban, A
    Schell, H
    Hohenberger, W
    Sauer, R
    HAUTARZT, 1999, 50 (08): : 572 - 579
  • [29] Long-term survival with modern therapeutic agents against metastatic melanoma—vemurafenib and ipilimumab in a daily life setting
    B. M. Lang
    A. Peveling-Oberhag
    D. Faidt
    A. M. Hötker
    V. Weyer-Elberich
    S. Grabbe
    C. Loquai
    Medical Oncology, 2018, 35
  • [30] Toxic epidermal necrolysis caused by vemurafenib in a metastatic malignant melanoma
    Flor, Duarte
    Pedroso, Mariana
    Coutinho, Ines
    Goncalo, Margarida
    BMJ CASE REPORTS, 2025, 18 (02)
12345